FTH1 and ovarian cancer: The results confirmed that in CACNA1G-AS1-overexpressing ovarian cancer cells, the red fluorescence intensity obviously increased, while these changes could be reversed through IGF2BP1 and FTH1 inhibition (Figs. 4E and 4F).